QUEBEC CITY — Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, anno
QUEBEC CITY -- Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, announces that its Board of Directors has approved the grant of options to purchase Shares (the “Options”) at an exercise price of $0.16 for a period of 10 years from the date of grant. An aggregate of 3,298,611 Options was granted to officers of the Corporation. These Options are exercisable on the grant date. Read More
